LACORE advised the Berlin based life science start-up on its pre-Series A financing round. The company received two million euros from the Munich based investor yabeo.
BIOMES uses state-of-the-art biotechnological methods to examine bacteria that live in and on the human body. The intestinal flora self-test – which was released as the first product 2018 - is now being marketed and sold internationally. The investment will be used for product development, further microbiome studies and the expansion of the corporate structure.
BIOMES has been advised by André Eggert and Sohrab Beheshtipour (both Corporate).